key: cord-0011567-g0nadfxu authors: Naeem, Asif; Elbakkouri, Karim; Alfaiz, Ali; Hamed, Maaweya E.; Alsaran, Hadel; AlOtaiby, Shahad; Enani, Mushira; Alosaimi, Bandar title: Antigenic drift of hemagglutinin and neuraminidase in seasonal H1N1 influenza viruses from Saudi Arabia in 2014 to 2015 date: 2020-04-01 journal: J Med Virol DOI: 10.1002/jmv.25759 sha: ac14980580ca7def6d0e31c164079f3a045bc389 doc_id: 11567 cord_uid: g0nadfxu Antigenic drift of the hemagglutinin (HA) and neuraminidase (NA) proteins of the influenza virus cause a decrease in vaccine efficacy. Since the information about the evolution of these viruses in Saudi is deficient so we investigated the genetic diversity of circulating H1N1 viruses. Nasopharyngeal aspirates/swabs collected from 149 patients hospitalized with flu‐like symptoms during 2014 and 2015 were analyzed. Viral RNA extraction was followed by a reverse transcription‐polymerase chain reaction and genetic sequencing. We analyzed complete gene sequences of HA and NA from 80 positive isolates. Phylogenetic analysis of HA and NA genes of 80 isolates showed similar topologies and co‐circulation of clades 6b. Genetic diversity was observed among circulating viruses belonging to clade 6B.1A. The amino acid residues in the HA epitope domain were under purifying selection. Amino acid changes at key antigenic sites, such as position S101N, S179N (antigenic site‐Sa), I233T (antigenic site‐Sb) in the head domain might have resulted in antigenic drift and emergence of variant viruses. For NA protein, 36% isolates showed the presence of amino acid changes such as V13I (n = 29), I314M (n = 29) and 12% had I34V (n = 10). However, H257Y mutation responsible for resistance to neuraminidase inhibitors was missing. The presence of amino acid changes at key antigenic sites and their topologies with structural mapping of residues under purifying selection highlights the importance of antigenic drift and warrants further characterization of recently circulating viruses in view of vaccine effectiveness. The co‐circulation of several clades and the predominance of clade 6B.1 suggest multiple introductions in Saudi. severe illness and 300 000 to 500 000 deaths. The disease burden and epidemiologic pattern of influenza is due to the changing nature of the antigenic properties of influenza viruses. 3 Influenza A virus undergoes periodic modifications in the antigenic properties of its envelope glycoproteins; the hemagglutinin (HA) and the neuraminidase (NA). Three major hemagglutinin subtypes (H1, H2, and H3) and two neuraminidase subtypes (N1 and N2) have evolved to human species subtypes of influenza A virus. 4 Influenza virus genome have eight RNA segments and rate of reassortment among co-infecting viruses can be high. 5, 6 Antigenic shift leads to the emergence of new strains by reassortment between animal and human influenza viruses. The pandemics of 1908, 1957, 1968, and 2009 were caused by new viruses emerging as a result of antigenic shift. 7, 8 Point mutations in the RNA segments coding for HA or NA are called antigenic drift. Antigenic drift causes less extensive and severe outbreaks. Between the years of antigenic shift, the variable extent and severity of influenza outbreaks is due to antigenic drift. 9 During World War I, Spanish flu pandemic killed 25 to 50 million people between 1918 and 1919 worldwide. 10 Spanish flu was one of the worst epidemics in the history of mankind killing healthy adults between 15 and 34 years. 11 The emergence of an antigenic shift in both hemagglutinin (H1) and neuraminidase (N1) proteins of the influenza A virus had extremely severe consequences. 12 The pathogenicity of the 1918 pandemic influenza virus was first demonstrated in a mouse model using reverse genetics. After infection in mice, the 1918 pandemic strain replicated efficiently producing 39 000 times more virus copies in the lungs compared to other H1N1 strains. 13 Since 1918, several influenza A virus pandemics have occurred. Genetic reassortment led to the emergence of the H2N2/1957 and H3N2/1968 pandemic influenza viruses. In 1957, the antigenic shift in the influenza A strain to H2 and N2 resulted in a severe pandemic causing approximately 1 million deaths worldwide. 14 The 1968 pandemic was less extensive due to an antigenic shift only in hemagglutinin gene (from H2N2 to H3N2). 15 The most recent emergence of the H1N1 influenza virus was in March 2009 in Mexico; however, the pandemic H1N1 virus circulation has continued globally ever since. In June 2009, the pandemic alert level (phase 6) was declared by the World Health Organization (WHO). More than 214 countries reported the confirmed cases of pandemic H1N1 influenza A virus. 16 17 The 2009 H1N1 influenza pandemic was also associated with 100 000 to 400 000 deaths due to respiratory infection and 46 000 to 180 000 deaths due to cardiovascular infections. 18, 19 The disease burden due to pandemic influenza A infection in the USA was 0.12 deaths per 100 000 individuals. 20 Severe pneumonia and acute respiratory distress syndrome caused most of the deaths. 21 The epidemiology of influenza A (H1N1) pdm09 with a molecular and phylogenetic analysis of HA gene during 2013/2014 influenza season in Canada, 22 in Dalian, 24 China, 25 Africa, 26 Europe, 27, 28 23, 25 However, it also revealed a trend of strains to accumulate amino acid variations as a result of multiple re-introductions and form new phylogenetic groups. Furthermore, a high number of the strains possessed the amino acid changes D97N (aspartic acid to asparagine), S185T (serine to threonine), K163Q (lysine to glutamine), A256T (alanine to threonine), and K283E (lysine to glutamic acid). 24 Influenza A (H1N1) 2009 pandemic viruses were initially reported in Saudi Arabia with the clinical features of the patients in 2010 from Saudi Arabia; the virus infection was confirmed by reverse transcription-polymerase chain reaction (RT-PCR). 30,31 Subsequent years have seen the studies reporting genetic diversity, phylogenetic relationships, and amino acid variations of HA and NA genes for influenza from the western region of Saudi Arabia. 32, 33 Antigenic drift leads to the emergence of novel strains with a capacity to replicate efficiently in humans after infection or vaccination. Since a close antigenic match is required between circulating and vaccine strains for the efficacy of vaccines, and the disease burden is increased due to mismatches, therefore it is important to identify the mutations that affect the antibody response against natural infection or vaccination. 34 Especially the antigenic sites of HA and NA, which affect the receptor binding properties 35 and virulence 36 are crucial for understanding antigenic drift. The current epidemiological and virological data on circulating influenza viruses in Saudi Arabia are quite deficient, and there is no influenza surveillance program in the country as well. 37 Most of the published work on H1N1 virus in Saudi Arabia deals with specimens originating in the western region during the 2009 influenza pandemic 33,37-39 and prevalence of different respiratory viruses including H1N1 [38] [39] [40] or surveillance studies involving the pilgrims. [41] [42] [43] [44] It is important to provide virological, molecular, and epidemiological information on circulating influenza strains, and its associated morbidity and mortality to make informed decisions and to undertake effective control measures to decrease the disease burden. Following the years of the pandemic, the virus undergoes antigenic drift and there is little published data about this phenomenon in Saudi Arabia. Therefore, we aimed to identify the circulation patterns, genetic diversity, structural and epidemiological characteristics of influenza A (H1N1) virus in Riyadh, Saudi Arabia from the flu season (2014-2015). The institutional review board at King Fahad Medical City reviewed and approved the study protocol (IRB register number 16-266). The handling of respiratory samples, as well as preparation of aliquots and viral RNA extraction, was executed using appropriate personal protective equipment in the biosafety level two-laboratory (Research Laboratories, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia). The study specimens were obtained from a population (n = 148) ad- Nasopharyngeal swabs and/or aspirates specimens were collected for laboratory-based investigations. Demographic information, medical history, and outcome information were collected. Respiratory specimens were used for influenza H1N1 initial screening and further molecular testing. Total RNA was extracted using QIAamp Viral RNA Mini Kit (Qiagen, MA). Swabs were dissolved in the lysis buffer. Eight RNA segments of influenza A virus were simultaneously reverse-transcribed (RT) and amplified by PCR using SuperScript III One Step RT-PCR System (Life Technologies, CA) with the primer pairs as described previously 7 . RT-PCR products were purified by ExoSAP-IT Express PCR Product Cleanup Reagent (Applied Biosystems, Foster City, CA). Highsensitivity microvolume nucleic acid quantitation was performed using the NanoDrop 3300 Fluorospectrometer. 45 The nucleotide sequences of the amplified HA and NA fragments from 80 isolates with high copy numbers were determined using M13, sequencing The NetNGlyc 1.0 server was used to predict potential N-linked glycosylation sites (amino acids Asn-X-Ser/Thr, whereby X is any amino acid except Asp or Pro). 47 A threshold value of >0.5 for the average potential score suggests glycosylation. The evolutionary relationships between the vaccine and con- (Table 1) . Four mutations were found in previously characterized 52 Ab-binding sites. The circulating strains belonged to subclade 6B.1, defined by HA amino acid substitutions S101N, S179N, and I233T. The majority of the 2014/15 season Saudi isolates formed part of a large cluster possessing an S101N substitution in HA. Most of these isolates contained S179N (on the Sa antigenic site of HA resulting in a potential glycosylation site) and I233T amino acid substitutions in addition to the S101N substitution and formed a subclade subsequently designated as 6B. 1. 48 As for the NA protein (sequenced from 80 nasopharyngeal aspirates and swabs), 14 amino acid changes were found when compared to the vaccine strain (Table 2 ). Five out of the fourteen changes (N200S, N248D, I321V, N369K, and K432E) were at previously characterized Ab-binding sites. 53 of the influenza virus in response to humoral immunity. 54 As shown on a 3D model of the HA protein (RCSB PDB ID: 3LZG), 55 five mutations were found in previously characterized 48 Ab-binding sites: S179N and T180Q, in Sa; P200S and S202T, in Sb; and S220T, in Ca1 ( Figure 2C and Table 1 ). 56 Further analyses of HA protein of study strains (Table 1) We assumed that the influenza HA protein is subjected to selection pressure to evade the host cell recognition, the rate of change was NAEEM ET AL. We did not find the D222G mutation commonly associated with increased virulence. 58 . The authors declare that there are no conflict of interests. Influenza (Seasonal) Fact sheet N 211 The evolution of human influenza viruses WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from New world bats harbor diverse influenza A viruses Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir Emergence of influenza A viruses Emergence of a novel swine-origin influenza A(H1N1) virus in humans Antigenic and genetic characteristics of the early isolates of swine-origin 2009 A(H1N1) influenza viruses circulating in humans The evolution of epidemic influenza Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic The 1918 influenza pandemic: insights for the 21st century Initial genetic characterization of the 1918 "Spanish" influenza virus Characterization of the reconstructed 1918 Spanish influenza pandemic virus Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man World Health Organization. Pandemic (H1N1) 2009: update 112 Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California Interim estimates of 2013/ 14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16-a rapid epidemiological and virological assessment Molecular epidemiology and phylogenetic analysis of HA gene of influenza A(H1N1)pdm09 strain during 2010-2014 in Dalian, North China Molecular epidemiology and evolution of influenza A and B viruses during winter 2013-2014 in Beijing Sentinel surveillance for influenza among severe acute respiratory infection and acute febrile illness inpatients at three hospitals in Ghana. Influenza Other Respir Viruses Genetic diversity of the haemagglutinin (HA) of human influenza A (H1N1) virus in Montenegro: focus on its origin and evolution Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia, Spain Emergence of influenza A (H1N1) pdm09 genogroup 6B and drug resistant virus Detection of the first case of swine flu in Saudi Arabia Filipina nurse Characteristics of patients hospitalized with 2009 H1N1 influenza in a tertiary carehospital in southern Saudi Arabia The Extinction Protocol. H1N1 outbreak reported in Saudi Arabia Genetic diversity of the pandemic influenza A (H1N1) virus in Saudi Arabia Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic Glycans on influenza hemagglutinin affect receptor binding and immune response Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice Influenza immunization and surveillance in Saudi Arabia The diagnostic challenge of pandemic H1N1 2009 virus in a dengue-endemic region: a case report of combined infection in Jeddah, Kingdom of Saudi Arabia Comparative analysis of hemagglutinin of 2009 H1N1 influenza A pandemic indicates its evolution to 1918H1N1 pandemic Clinical and laboratory characteristics of childhood pandemic 2009 H1N1 Influenza. Experience from the western region of Saudi Arabia Pandemic 2009 influenza A (H1N1) infection among 2009 Hajj Pilgrims from Southern Iran: a real-time RT-PCR-based study. Influenza Other Respir Viruses Detection of respiratory viruses among pilgrims in Saudi Arabia during the time of a declared influenza A(H1N1) pandemic Demographic distribution and transmission potential of influenza A and 2009 pandemic influenza A H1N1 in pilgrims Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015 NanoDrop microvolume quantitation of nucleic acids a suite of phylogenetic analysis tools for evolutionary biology Prediction of N-glycosylation sites in human proteins The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) Recommended composition of influenza virus vaccines for use in the 2017-2018 northern hemisphere influenza season Positive selection at the receptorbinding site of hemagglutinin H5 in viral sequences derived from human tissues Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus A perspective on the structural and functional constraints for immune evasion: insights from influenza virus Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses The population genetics of dN/dS Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe Influenza surveillance in Middle East, North, East and South Africa: report of the 8th MENA Influenza Stakeholders Network. Influenza Other Respir Viruses Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A (H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany nextflu: real-time tracking of seasonal influenza virus evolution in humans Genome-wide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea Recommended composition of influenza virus vaccines for use in the 2019-2020 northern hemisphere influenza season Incidence of influenza A H1N1 2009 infection in Eastern Saudi Arabian hospitals Silver Spring, MD: Department of Health and Human Services, Food and Drug Administration Silver Spring, MD: Department of Health and Human Services, Food and Drug Administration Host defenses against influenza virus: the role of antihemagglutinin antibody Evolving complexities of influenza virus and its receptors Antibody to influenza virus neuraminidase: an independent correlate of protection In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase Genetic characterization of hemagglutinin (HA) gene of influenza A viruses circulating in Southwest India during 2017 season Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies The hemagglutinin of the influenza A(H1N1) pdm09 is mutating towards stability Antigenic drift of hemagglutinin and neuraminidase in seasonal H1N1 influenza viruses from Saudi Arabia in 2014 to